Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05144100 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial

Study acronym: SCOPE
StatusNot Yet Recruiting
PhasePhase 2/3
Started2021-12-01
View on ClinicalTrials.gov ↗
The oropharyngeal areas mainly comprises of the tonsil, base tongue (BOT), soft palate and the posterior pharyngeal wall. Traditionally, surgical resection of oropharyngeal cancers (OPC) was a standard procedure, often performed through mutilating incisions with mandibulotomies, rendering significant post-operative functional deficits. Over the past 2 decades, there has been a major shift in treatment strategy with a majority of these cancers now being treated by primary concurrent chemoradiation (CCRT) with a trend towards organ and function preservation.
Trial Details
NCT Number NCT05144100
Lead Sponsor Tata Memorial Centre
Collaborators: All India Institute of Medical Sciences, Amrita Institute of Medical Sciences & Research Center
Conditions Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Enrollment 498 participants
Start Date 2021-12-01
Primary Completion 2029-06-30 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2021-12-03